While the relationship between the TMPRSS2-ERG fusion and PCP4 deletion or CAMKK2 activity was not specifically investigated here, no evidence emerged to suggest CAMKK2 inhibitors affect tumor progression in TMPRSS2-ERG gene fusion cases. Here, CAMKK2 is linked to neoplasm.